Testing effectiveness (Phase 2)WithdrawnNCT04535102What this trial is testingPOLA+BR for Relapsed or Refractory DLBCLWho this might be right forDiffuse Large B Cell Lymphoma University of Colorado, Denver
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872What this trial is testingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 547
Testing effectiveness (Phase 2)Temporarily pausedNCT04855253What this trial is testingPh I/II Study of E7777 Prior to CAR-T for R/R LBCLWho this might be right forDLBCLDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more Masonic Cancer Center, University of Minnesota 30
Not applicableStudy completedNCT04872621What this trial is testingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma) AstraZeneca 104
Not applicableLooking for participantsNCT06534463What this trial is testingRegistry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)Who this might be right forMarginal Zone Lymphoma Ruijin Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Testing effectiveness (Phase 2)Study completedNCT02458014What this trial is testingBlinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual DiseaseWho this might be right forAdult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22
Testing effectiveness (Phase 2)UnknownNCT05385263What this trial is testingAddition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at LymphodepletionWho this might be right forB Cell Lymphoma Tel-Aviv Sourasky Medical Center 20
Not applicableStudy completedNCT00281814What this trial is testingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 36
Early research (Phase 1)WithdrawnNCT03807063What this trial is testingRivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWho this might be right forAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07516093What this trial is testingStudy of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLWho this might be right forB-cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Nurix Therapeutics, Inc. 620
Testing effectiveness (Phase 2)UnknownNCT04025593What this trial is testingBiomarker Guided Treatment in DLBCLWho this might be right forDiffuse Large B Cell Lymphoma Ruijin Hospital 128
Testing effectiveness (Phase 2)Ended earlyNCT05405309What this trial is testingRP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia University of Utah 5
Testing effectiveness (Phase 2)Ended earlyNCT00905398What this trial is testingNilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forPrecursor B-Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia Rony Schaffel 8
Testing effectiveness (Phase 2)Study completedNCT01775475What this trial is testingIntravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin LymphomaWho this might be right forAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more AIDS Malignancy Consortium 7
Early research (Phase 1)Active Not RecruitingNCT02935257What this trial is testingImmunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19Who this might be right forLeukemia, Lymphoblastic, Acute, Lymphoma University College, London 72
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Very early researchEnded earlyNCT04034446What this trial is testingCD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)Who this might be right forRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia Institute of Hematology & Blood Diseases Hospital, China 2
Testing effectiveness (Phase 2)Ended earlyNCT01403246What this trial is testingChlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 9